| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.1M | -33.2% | -22.0% |
| Cost of Revenue | $1.9M | — | +35.6% |
| R&D Expense | $1.5M | — | +12.6% |
| SG&A Expense | $2.6M | — | +3.7% |
| Operating Income | -$3.1M | -128.2% | -342.2% |
| Interest Expense | $86K | — | -47.6% |
| Pre-tax Income | -$3.1M | — | -350.2% |
| Income Tax | $4K | — | -31.7% |
| Net Income | -$3.3M | -133.0% | -361.7% |
| EPS (Basic) | -$0.22 | -144.4% | -375.0% |
| EPS (Diluted) | -$0.22 | -144.4% | -375.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.0M | -3.8% | -27.1% |
| Accounts Receivable | $14.3M | -15.8% | +36.0% |
| Inventory | $5.5M | -12.4% | +33.1% |
| Current Assets | $32.8M | -11.5% | +2.9% |
| Total Assets | $71.0M | -7.6% | +1.5% |
| Current Liabilities | $34.5M | -6.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $387K | — | -90.1% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$61K | — | +95.0% |
| Financing Cash Flow | -$763K | — | +86.2% |
| Free Cash Flow | $387K | — | -89.9% |
| +35.1% |
| Total Liabilities | $49.7M | -4.9% | +19.5% |
| Stockholders' Equity | $21.6M | -13.0% | -24.5% |